Back to Agenda
Welcome and Opening Remarks
Speaker(s)
Robert T. Dorsam, PHD
FDA, United States
Associate Director, Pharmacology/Toxicology, Office of Generic Drugs, CDER
Jim Zisek
GlaxoSmithKline, United States
Director, Global CMC Regulatory Affairs
Have an account?